Healthcare Triangle, Inc. Commitments Disclosure
7) Contingent consideration
The Company recognized an initial value of $2,227 in financial year 2021 as contingent consideration towards acquisition of Devcool Inc.
As on December 31, 2022, based on the actual revenue and profitability achievement, the fair value of the contingent consideration liability was remeasured at $625, resulting in a gain of $1,602, which was recognized as “Gain on revaluation” in the consolidated income statement. The gain on revaluation was $0 in the financial year 2023.
The Company has a payout of $625 for financial year 2022 and $0 for financial year 2023 arising from the Devcool Inc, acquisition. During the year ended December 31, 2023, the company issued 31,250 common stocks valued at $125 towards settlement of the contingent consideration and the balance $500 is outstanding as of December 31, 2024.
On February 24, 2025, the Company executed a settlement agreement and issued 594,130 common stocks at 10-day VWAP of $0.6733 amounting to $400 and the balance $100 to be settled by cash on March 31, 2025.
About Commitments Disclosures
Commitments and contingencies disclosures catalog a company's off-balance-sheet obligations and legal exposures — purchase commitments, guarantee arrangements, pending litigation, and regulatory proceedings. These items represent potential future cash outflows that may not appear as liabilities on the balance sheet until they become probable and estimable.
Key signals: litigation reserves and disclosed loss ranges quantify management's estimate of legal exposure, but unquantified "reasonably possible" losses often represent the larger risk. Watch for changes in language around pending cases — shifts from "remote" to "reasonably possible" or increases in estimated loss ranges signal deteriorating outcomes. Unconditional purchase obligations and take-or-pay contracts create fixed cost structures that reduce operational flexibility. Guarantee arrangements for subsidiaries or joint ventures can create cascading obligations. Compare the total commitment schedule against projected free cash flow to assess whether the company can meet its obligations without additional financing.